Vnitr Lek 2022, 68(5):295-302 | DOI: 10.36290/vnl.2022.063
What's new in 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice?
- 1 I. interní klinika - kardiologická, Fakultní nemocnice Olomouc
- 2 Interní a kardiologická klinika, Fakultní nemocnice Ostrava
- 3 Katedra interních oborů, Lékařská fakulta Ostravské Univerzity
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice provides a comprehensive view on preventive cardiology. It presents strategies to reduce the burden of atherosclerotic cardiovascular disease (CVD), both at the individual level and at the population level. Healthy lifestyle and aggressive control of cardiovascular risk factors remain the cornerstone of prevention. Classification of individuals into risk groups based on their clinical characteristics followed by a stepwise treatment-intensification is a novel recommended approach. Updated risk charts - SCORE2 and SCORE2-OP - are intended for estimation of 10-year fatal and non-fatal CVD risk in apparently healthy individuals. Targets and goals for LDL cholesterol, blood pressure, and glycaemic control remain as recommended in recent ESC Guidelines.
Keywords: atherosclerotic cardiovascular disease, cardiovascular risk factors, healthy lifestyle, prevention, SCORE2 and SCORE2-OP.
Accepted: August 4, 2022; Published: August 22, 2022 Show citation
References
- Visseren FLJ, Mach F, Smulders YM et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337. doi:10.1093/eurheartj/ehab484
Go to original source... 
Go to PubMed... - Vrablík M, Cífková R, Tuka V, Linhart A. Doporučený postup Evropské kardiologické společnosti pro prevenci kardiovaskulárních onemocnění v klinické praxi 2021. Souhrn dokumentu připravený Českou kardiologickou společností. Cor Vasa 2022;64:165-211. Go to original source...
- Cosentino F, Grant PJ, Aboyans V et al. 2019 ESC Guidelines on diabetes, pre‑diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255-323. doi:10.1093/eurheartj/ehz486. Go to original source... Go to PubMed...
- Mach F, Baigent C, Catapano AL et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188. doi:10.1093/eurheartj/ehz455. Go to original source... Go to PubMed...
- Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104. doi:10.1093/eurheartj/ehy339. Go to original source... Go to PubMed...